Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

3.69
Delayed Data
As of 4:00pm ET
 +0.06 / +1.65%
Today’s Change
1.61
Today|||52-Week Range
5.44
+20.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues5.0M9.0M5.7M3.2M
 
 
 
 
 
Cost of Goods Sold392.7K1.5M264.9K421.5K
 
 
 
 
 
Depreciation And Amortization1.0M569.4K578.1K737.7K
 
 
 
 
 
 
Operating ExpensesGross Income3.5M6.9M4.8M2.1M
 
 
 
 
 
General Expenses35.1M42.5M51.0M61.1M
 
 
 
 
 
Research And Development29.2M33.1M41.2M53.5M
 
 
 
 
 
Total Operating Expenses36.5M44.6M51.9M62.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.6M-35.6M-46.2M-59.0M
 
 
 
 
 
Extraordinary Credit16.7M0.000.000.00
 
 
Interest Expense On Debt----2.1M5.5M
 
 
 
Other Expenses2.6M938.009.8K-37.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.2M-35.5M-48.1M-64.2M
 
 
 
 
 
Income Taxes-44.1K-7.8K-58.2K-5.1M
 
 
 
 
 
Minority Interest-104.8K-105.4K-121.6K-98.8K
 
 
 
 
 
Net Income-12.2M-35.4M-48.0M-59.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.0M84.6M93.3M94.8M
 
 
 
 
 
Shares To Calculate EPS Diluted78.0M84.6M93.3M94.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.42-$0.51-$0.62
 
 
 
 
 
EPS Diluted-$0.16-$0.42-$0.51-$0.62